Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations

被引：0

|

作者：

Nancy Crudele

Jennifer Giordano

机构：

[1] Purdue Pharma L.P.,Medical Affairs

来源：

Clinical Drug Investigation | 2018年 / 38卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：795 / 797

页数：2

相关论文

共 7 条

[1] Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations
Crudele, Nancy
Giordano, Jennifer
[J]. CLINICAL DRUG INVESTIGATION, 2018, 38 (08) : 795 - 797
[2] In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations
Stephen P. Mayock
Said Saim
Alison B. Fleming
[J]. Clinical Drug Investigation, 2017, 37 : 1117 - 1124
[3] Author Correction to: In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations
Stephen P. Mayock
Said Saim
Alison B. Fleming
[J]. Clinical Drug Investigation, 2017, 37 : 1203 - 1203
[4] Response to Crudele et al. Commentary on Mayock et al. “In Vitro Drug Release after Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations”
Alison B. Fleming
Stephen P. Mayock
Said Saim
[J]. Clinical Drug Investigation, 2018, 38 : 799 - 800
[5] Response to Crudele et al. Commentary on Mayock et al. "In Vitro Drug Release after Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations"
Fleming, Alison B.
Mayock, Stephen P.
Saim, Said
[J]. CLINICAL DRUG INVESTIGATION, 2018, 38 (08) : 799 - 800
[6] In Vitro Drug Release After Crushing: Evaluation of Xtampza® ER and Other ER Opioid Formulations (vol 37, pg 1117, 2017)
Mayock, Stephen P.
Saim, Said
Fleming, Alison B.
[J]. CLINICAL DRUG INVESTIGATION, 2017, 37 (12) : 1203 - 1203
[7] In Vitro Drug Release After Crushing: Evaluation of XtampzaA® ER and Other ER Opioid Formulations
Mayock, Stephen P.
Saim, Said
Fleming, Alison B.
[J]. CLINICAL DRUG INVESTIGATION, 2017, 37 (12) : 1117 - 1124